Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Barclays Global Healthcare Conference on Wednesday, March 16, 2016, at 8:30 a.m. EDT (12:30 p.m. GMT) from the Loews Miami Beach Hotel. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160309006292/en/
Contacts:
Sandra Coombs, +1 781 609 6377
Corporate
Communications